4.6 Article

Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Multifunctional nanoparticles for brain tumor imaging and therapy

Yu Cheng et al.

ADVANCED DRUG DELIVERY REVIEWS (2014)

Article Cell Biology

Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates

Y. Joy Yu et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Review Biochemistry & Molecular Biology

Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System

Erin M. McConnell et al.

NUCLEIC ACID THERAPEUTICS (2014)

Review Clinical Neurology

The global prevalence of dementia: A systematic review and metaanalysis

Martin Prince et al.

ALZHEIMERS & DEMENTIA (2013)

Article Biochemical Research Methods

Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations

Yechun Xu et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2012)

Review Biochemistry & Molecular Biology

Alzheimer Mechanisms and Therapeutic Strategies

Yadong Huang et al.

Review Chemistry, Medicinal

Small-molecule BACE1 inhibitors: a patent literature review (2006-2011)

Gary Probst et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2012)

Article Biochemistry & Molecular Biology

Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease

Fredrik Jeppsson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

A mutation in APP protects against Alzheimer's disease and age-related cognitive decline

Thorlakur Jonsson et al.

NATURE (2012)

Review Chemistry, Analytical

Aptamers and Their Biological Applications

Kyung-Mi Song et al.

SENSORS (2012)

Article Chemistry, Medicinal

Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability

Michael S. Malamas et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Biochemistry & Molecular Biology

BACE: Therapeutic target and potential biomarker for Alzheimer's disease

Genevieve Evin et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice

Ryoichi Kimura et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Review Biotechnology & Applied Microbiology

Aptamers as therapeutics

Anthony D. Keefe et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Article Neurosciences

Aptamers as Innovative Diagnostic and Therapeutic Agents in the Central Nervous System

Vittorio de Franciscis et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)

Article Oncology

Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX

Shaohua Li et al.

JOURNAL OF PATHOLOGY (2009)

Article Biochemistry & Molecular Biology

Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus

Xiaoxiao Cao et al.

NUCLEIC ACIDS RESEARCH (2009)

Article Multidisciplinary Sciences

Differential SELEX in Human Glioma Cell Lines

Laura Cerchia et al.

PLOS ONE (2009)

Review Clinical Neurology

BACE1 structure and function in health and Alzheimer's disease

Sarah L. Cole et al.

CURRENT ALZHEIMER RESEARCH (2008)

Article Biochemistry & Molecular Biology

The proteins BACE1 and BACE2 and β-secretase activity in normal and Alzheimer's disease brain

J. H. Stockley et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2007)

Article Biochemistry & Molecular Biology

Structure of an RNA polymerase II-RNA inhibitor complex elucidates transcription regulation by noncoding RNAs

H Kettenberger et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)